Product Code: IRTNTR40309
Technavio has been monitoring the drug discovery informatics market and is forecast to grow by USD 4,953.48 mn during 2022-2027, accelerating at a CAGR of 15.06% during the forecast period. Our report on the drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing R and D investments by pharmaceutical and biopharmaceutical companies, drug discovery with reduced time and cost by using in-silico modeling tools, and increasing outsourcing activities for drug discovery.
Technavio's drug discovery informatics market is segmented as below:
By Application
- Discovery informatics
- Development informatics
By Solution
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing number of clinical trials as one of the prime reasons driving the drug discovery informatics market growth during the next few years. Also, the rising adoption of AI tools and the rising emergence of personalized medicine will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the drug discovery informatics market covers the following areas:
- Drug discovery informatics market sizing
- Drug discovery informatics market forecast
- Drug discovery informatics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug discovery informatics market vendors that include Aragen Life Sciences Pvt. Ltd., Certara Inc., Charles River Laboratories International Inc., ChemAxon Ltd., ChemBridge Corp., Collaborative Drug Discovery Inc., Cresset BioMolecular Discovery Ltd., Curia Global Inc., Dassault Systemes SE, Eurofins Scientific SE, Evotec SE, Infosys Ltd., Insilico Medicine, International Business Machines Corp., Jubilant Pharmova Ltd., Melissa Inc., OpenEye Scientific Software Inc., Perkin Elmer Inc., Schrodinger Inc., Selvita SA, and Thermo Fisher Scientific Inc.. Also, the drug discovery informatics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market by Geography
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Solution
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global drug discovery informatics market 2017 - 2021
- Exhibit 18: Historic Market Size - Data Table on Global drug discovery informatics market 2017 - 2021 ($ million)
- 4.2 Application Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
- 4.3 Solution Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Discovery informatics - Market size and forecast 2022-2027
- Exhibit 34: Chart on Discovery informatics - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Discovery informatics - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Discovery informatics - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Discovery informatics - Year-over-year growth 2022-2027 (%)
- 6.4 Development informatics - Market size and forecast 2022-2027
- Exhibit 38: Chart on Development informatics - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Development informatics - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Development informatics - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Development informatics - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Solution
- 7.1 Market segments
- Exhibit 44: Chart on Solution - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Solution - Market share 2022-2027 (%)
- 7.2 Comparison by Solution
- Exhibit 46: Chart on Comparison by Solution
- Exhibit 47: Data Table on Comparison by Solution
- 7.3 Software - Market size and forecast 2022-2027
- Exhibit 48: Chart on Software - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Software - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Software - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Software - Year-over-year growth 2022-2027 (%)
- 7.4 Services - Market size and forecast 2022-2027
- Exhibit 52: Chart on Services - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Services - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Services - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Services - Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Solution
- Exhibit 56: Market opportunity by Solution ($ million)
- Exhibit 57: Data Table on Market opportunity by Solution ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 UK - Market size and forecast 2022-2027
- Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.10 France - Market size and forecast 2022-2027
- Exhibit 91: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.11 China - Market size and forecast 2022-2027
- Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 104: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 105: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification
- 12.3 Certara Inc.
- Exhibit 107: Certara Inc. - Overview
- Exhibit 108: Certara Inc. - Product / Service
- Exhibit 109: Certara Inc. - Key news
- Exhibit 110: Certara Inc. - Key offerings
- 12.4 Charles River Laboratories International Inc.
- Exhibit 111: Charles River Laboratories International Inc. - Overview
- Exhibit 112: Charles River Laboratories International Inc. - Business segments
- Exhibit 113: Charles River Laboratories International Inc. - Key news
- Exhibit 114: Charles River Laboratories International Inc. - Key offerings
- Exhibit 115: Charles River Laboratories International Inc. - Segment focus
- 12.5 ChemAxon Ltd.
- Exhibit 116: ChemAxon Ltd. - Overview
- Exhibit 117: ChemAxon Ltd. - Product / Service
- Exhibit 118: ChemAxon Ltd. - Key offerings
- 12.6 ChemBridge Corp.
- Exhibit 119: ChemBridge Corp. - Overview
- Exhibit 120: ChemBridge Corp. - Product / Service
- Exhibit 121: ChemBridge Corp. - Key offerings
- 12.7 Collaborative Drug Discovery Inc.
- Exhibit 122: Collaborative Drug Discovery Inc. - Overview
- Exhibit 123: Collaborative Drug Discovery Inc. - Product / Service
- Exhibit 124: Collaborative Drug Discovery Inc. - Key offerings
- 12.8 Cresset BioMolecular Discovery Ltd.
- Exhibit 125: Cresset BioMolecular Discovery Ltd. - Overview
- Exhibit 126: Cresset BioMolecular Discovery Ltd. - Product / Service
- Exhibit 127: Cresset BioMolecular Discovery Ltd. - Key offerings
- 12.9 Curia Global Inc.
- Exhibit 128: Curia Global Inc. - Overview
- Exhibit 129: Curia Global Inc. - Product / Service
- Exhibit 130: Curia Global Inc. - Key news
- Exhibit 131: Curia Global Inc. - Key offerings
- 12.10 Dassault Systemes SE
- Exhibit 132: Dassault Systemes SE - Overview
- Exhibit 133: Dassault Systemes SE - Product / Service
- Exhibit 134: Dassault Systemes SE - Key news
- Exhibit 135: Dassault Systemes SE - Key offerings
- 12.11 Evotec SE
- Exhibit 136: Evotec SE - Overview
- Exhibit 137: Evotec SE - Business segments
- Exhibit 138: Evotec SE - Key news
- Exhibit 139: Evotec SE - Key offerings
- Exhibit 140: Evotec SE - Segment focus
- 12.12 Infosys Ltd.
- Exhibit 141: Infosys Ltd. - Overview
- Exhibit 142: Infosys Ltd. - Business segments
- Exhibit 143: Infosys Ltd. - Key news
- Exhibit 144: Infosys Ltd. - Key offerings
- Exhibit 145: Infosys Ltd. - Segment focus
- 12.13 International Business Machines Corp.
- Exhibit 146: International Business Machines Corp. - Overview
- Exhibit 147: International Business Machines Corp. - Business segments
- Exhibit 148: International Business Machines Corp. - Key offerings
- Exhibit 149: International Business Machines Corp. - Segment focus
- 12.14 Jubilant Pharmova Ltd.
- Exhibit 150: Jubilant Pharmova Ltd. - Overview
- Exhibit 151: Jubilant Pharmova Ltd. - Business segments
- Exhibit 152: Jubilant Pharmova Ltd. - Key news
- Exhibit 153: Jubilant Pharmova Ltd. - Key offerings
- Exhibit 154: Jubilant Pharmova Ltd. - Segment focus
- 12.15 Melissa Inc.
- Exhibit 155: Melissa Inc. - Overview
- Exhibit 156: Melissa Inc. - Product / Service
- Exhibit 157: Melissa Inc. - Key offerings
- 12.16 OpenEye Scientific Software Inc.
- Exhibit 158: OpenEye Scientific Software Inc. - Overview
- Exhibit 159: OpenEye Scientific Software Inc. - Product / Service
- Exhibit 160: OpenEye Scientific Software Inc. - Key offerings
- 12.17 Perkin Elmer Inc.
- Exhibit 161: Perkin Elmer Inc. - Overview
- Exhibit 162: Perkin Elmer Inc. - Business segments
- Exhibit 163: Perkin Elmer Inc. - Key news
- Exhibit 164: Perkin Elmer Inc. - Key offerings
- Exhibit 165: Perkin Elmer Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources
- 13.5 List of abbreviations
- Exhibit 172: List of abbreviations